首页 > 最新文献

Reviews in urology最新文献

英文 中文
A case of pelvic organ prolapse in the setting of cirrhotic ascites. 肝硬化腹水并发盆腔器官脱垂1例。
Pub Date : 2016-01-01 DOI: 10.3909/RIU0702
Nima M. Shah, N. Ginzburg, K. Whitmore
Ascites is commonly found in patients with liver cirrhosis. Although conservative therapy is often the ideal choice of care with these patients who also have symptomatic pelvic organ prolapse, this may fail and surgical methods may be needed. Literature is limited regarding surgical repair of prolapse in the setting of ascites. The authors present the surgical evaluation and management of a 63-year-old woman with recurrent ascites from liver cirrhosis who failed conservative therapy. With adequate multidisciplinary care and medical optimization, this patient underwent surgical therapy with resolution of her symptomatic prolapse and improved quality of life.
腹水常见于肝硬化患者。虽然保守治疗通常是治疗这些伴有症状性盆腔器官脱垂的患者的理想选择,但这可能会失败,可能需要手术方法。文献是有限的手术修复脱垂在设置腹水。作者介绍了一例保守治疗失败的63岁女性肝硬化复发性腹水的手术评估和处理。在充分的多学科护理和医疗优化下,该患者接受了手术治疗,症状性脱垂得到了解决,生活质量得到了改善。
{"title":"A case of pelvic organ prolapse in the setting of cirrhotic ascites.","authors":"Nima M. Shah, N. Ginzburg, K. Whitmore","doi":"10.3909/RIU0702","DOIUrl":"https://doi.org/10.3909/RIU0702","url":null,"abstract":"Ascites is commonly found in patients with liver cirrhosis. Although conservative therapy is often the ideal choice of care with these patients who also have symptomatic pelvic organ prolapse, this may fail and surgical methods may be needed. Literature is limited regarding surgical repair of prolapse in the setting of ascites. The authors present the surgical evaluation and management of a 63-year-old woman with recurrent ascites from liver cirrhosis who failed conservative therapy. With adequate multidisciplinary care and medical optimization, this patient underwent surgical therapy with resolution of her symptomatic prolapse and improved quality of life.","PeriodicalId":94353,"journal":{"name":"Reviews in urology","volume":"39 1","pages":"178-180"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87427569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A novel approach to mesh revision after sacrocolpopexy. 骶髋固定术后补片修补的新方法。
Pub Date : 2016-01-01 DOI: 10.3909/RIU0698
Melissa L. Dawson, Rinko Rebecca, Nima M. Shah, K. Whitmore
Pelvic organ prolapse (POP) is the herniation of pelvic organs to or beyond the vaginal walls. POP affects 50% of parous women; of those women, 11% will need surgery based on bothersome symptoms. Transvaginal mesh has been used for vaginal augmentation since the 1990s. Complications from mesh use are now more prominent, and include chronic pelvic pain, dyspareunia, vaginal mesh erosion, and urinary and defecatory dysfunction. Presently, there is no consensus regarding treatment of these complications. Reported herein are two cases of women with defecatory dysfunction and pain after sacrocolpopexy who underwent mesh revision procedures performed with both urogynecologic and colorectal surgery.
盆腔器官脱垂(POP)是盆腔器官向阴道壁或阴道壁外的突出。持久性有机污染物影响50%的产妇;在这些女性中,11%的人会因为令人烦恼的症状而需要手术。自20世纪90年代以来,经阴道网状物已被用于阴道隆胸。使用补片的并发症现在更加突出,包括慢性盆腔疼痛、性交困难、阴道补片糜烂、泌尿和排便功能障碍。目前,对于这些并发症的治疗尚无共识。本文报告两例骶骶固定术后出现排便功能障碍和疼痛的妇女,她们接受了泌尿妇科和结直肠手术的补片翻修手术。
{"title":"A novel approach to mesh revision after sacrocolpopexy.","authors":"Melissa L. Dawson, Rinko Rebecca, Nima M. Shah, K. Whitmore","doi":"10.3909/RIU0698","DOIUrl":"https://doi.org/10.3909/RIU0698","url":null,"abstract":"Pelvic organ prolapse (POP) is the herniation of pelvic organs to or beyond the vaginal walls. POP affects 50% of parous women; of those women, 11% will need surgery based on bothersome symptoms. Transvaginal mesh has been used for vaginal augmentation since the 1990s. Complications from mesh use are now more prominent, and include chronic pelvic pain, dyspareunia, vaginal mesh erosion, and urinary and defecatory dysfunction. Presently, there is no consensus regarding treatment of these complications. Reported herein are two cases of women with defecatory dysfunction and pain after sacrocolpopexy who underwent mesh revision procedures performed with both urogynecologic and colorectal surgery.","PeriodicalId":94353,"journal":{"name":"Reviews in urology","volume":"17 1","pages":"174-177"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74624793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Prostate Cancer Academy 2016: Presentation summaries. 前列腺癌学会2016:报告总结。
Pub Date : 2016-01-01 DOI: 10.3909/riuPCA2016
E. Crawford, D. Albala, James S Wysocki, H. Lepor, A. Ross, S. Finkelstein, T. Keane, S. Freedland, R. Harris, N. Shore, C. Ryan
{"title":"Prostate Cancer Academy 2016: Presentation summaries.","authors":"E. Crawford, D. Albala, James S Wysocki, H. Lepor, A. Ross, S. Finkelstein, T. Keane, S. Freedland, R. Harris, N. Shore, C. Ryan","doi":"10.3909/riuPCA2016","DOIUrl":"https://doi.org/10.3909/riuPCA2016","url":null,"abstract":"","PeriodicalId":94353,"journal":{"name":"Reviews in urology","volume":"27 1","pages":"205-213"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74135882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conservative Management of Urinary Incontinence in Women. 女性尿失禁的保守治疗。
Pub Date : 2015-01-01
Izak Faiena, Neal Patel, Jaspreet S Parihar, Marc Calabrese, Hari Tunuguntla

Urinary incontinence in women has a high prevalence and causes significant morbidity. Given that urinary incontinence is not generally a progressive disease, conservative therapies play an integral part in the management of these patients. We conducted a nonsystematic review of the literature to identify high-quality studies that evaluated the different components of conservative management of stress urinary incontinence, including behavioral therapy, bladder training, pelvic floor muscle training, lifestyle changes, mechanical devices, vaginal cones, and electrical stimulation. Urinary incontinence can have a severe impact on our healthcare system and patients' quality of life. There are currently a wide variety of treatment options for these patients, ranging from conservative treatment to surgical treatment. Although further research is required in the area of conservative therapies, nonsurgical treatments are effective and are preferred by some patients.

女性尿失禁的发病率很高,并导致严重的发病率。鉴于尿失禁通常不是一种进展性疾病,保守疗法在这些患者的治疗中发挥着不可或缺的作用。我们对文献进行了一次非系统性回顾,以确定对压力性尿失禁保守治疗的不同组成部分进行评估的高质量研究,包括行为疗法、膀胱训练、盆底肌肉训练、生活方式改变、机械装置、阴道锥体和电刺激。尿失禁会对我们的医疗系统和患者的生活质量造成严重影响。目前,针对这些患者的治疗方法多种多样,从保守治疗到手术治疗,不一而足。虽然在保守疗法方面还需要进一步的研究,但非手术疗法是有效的,也是一些患者的首选。
{"title":"Conservative Management of Urinary Incontinence in Women.","authors":"Izak Faiena, Neal Patel, Jaspreet S Parihar, Marc Calabrese, Hari Tunuguntla","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Urinary incontinence in women has a high prevalence and causes significant morbidity. Given that urinary incontinence is not generally a progressive disease, conservative therapies play an integral part in the management of these patients. We conducted a nonsystematic review of the literature to identify high-quality studies that evaluated the different components of conservative management of stress urinary incontinence, including behavioral therapy, bladder training, pelvic floor muscle training, lifestyle changes, mechanical devices, vaginal cones, and electrical stimulation. Urinary incontinence can have a severe impact on our healthcare system and patients' quality of life. There are currently a wide variety of treatment options for these patients, ranging from conservative treatment to surgical treatment. Although further research is required in the area of conservative therapies, nonsurgical treatments are effective and are preferred by some patients. </p>","PeriodicalId":94353,"journal":{"name":"Reviews in urology","volume":"17 3","pages":"129-39"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633656/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141072372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metabolic Syndrome and Nephrolithiasis Risk: Should the Medical Management of Nephrolithiasis Include the Treatment of Metabolic Syndrome? 代谢综合征与肾结石风险:肾结石的医学管理是否应包括代谢综合征的治疗?
Pub Date : 2015-01-01 DOI: 10.3909/RIU0650
J. DiBianco, T. Jarrett, Patrick W. Mufarrij
This article reviews the relationship between metabolic syndrome (MetS) and nephrolithiasis, as well as the clinical implications for patients with this dual diagnosis. MetS, estimated to affect 25% of adults in the United States, is associated with a fivefold increase in the risk of developing diabetes, a doubling of the risk of acquiring cardiovascular disease, and an increase in overall mortality. Defined as a syndrome, MetS is recognized clinically by numerous constitutive traits, including abdominal obesity, hypertension, dyslipidemia (elevated triglycerides, low high-density lipoprotein cholesterol), and hyperglycemia. Urologic complications of MetS include a 30% higher risk of nephrolithiasis, with an increased percentage of uric acid nephrolithiasis in the setting of hyperuricemia, hyperuricosuria, low urine pH, and low urinary volume. Current American Urological Association and European Association of Urology guidelines suggest investigating the etiology of nephrolithiasis in affected individuals; however, there is no specific goal of treating MetS as part of the medical management. Weight loss and exercise, the main lifestyle treatments of MetS, counter abdominal obesity and insulin resistance and reduce the incidence of cardiovascular events and the development of diabetes. These recommendations may offer a beneficial adjunctive treatment option for nephrolithiasis complicated by MetS. Although definitive therapeutic recommendations must await further studies, it seems both reasonable and justifiable for the urologist, as part of a multidisciplinary team, to recommend these important lifestyle changes to patients with both conditions. These recommendations should accompany the currently accepted management of nephrolithiasis.
本文综述了代谢综合征(MetS)与肾结石之间的关系,以及对这种双重诊断的患者的临床意义。据估计,MetS影响美国25%的成年人,与患糖尿病的风险增加五倍、患心血管疾病的风险增加一倍以及总体死亡率增加有关。作为一种综合征,MetS在临床上被认为具有许多构成特征,包括腹部肥胖、高血压、血脂异常(甘油三酯升高、低高密度脂蛋白胆固醇)和高血糖。MetS的泌尿系统并发症包括肾结石的风险增加30%,尿酸肾结石的比例在高尿酸血症、高尿酸尿、低尿pH值和低尿量的情况下增加。目前美国泌尿学协会和欧洲泌尿学协会的指南建议调查受影响个体肾结石的病因;然而,并没有将MetS作为医疗管理的一部分来治疗的具体目标。减肥和运动是治疗MetS的主要生活方式,对抗腹部肥胖和胰岛素抵抗,减少心血管事件的发生和糖尿病的发展。这些建议可能为肾结石合并MetS提供有益的辅助治疗选择。虽然明确的治疗建议需要等待进一步的研究,但作为多学科团队的一部分,泌尿科医生向患有这两种疾病的患者推荐这些重要的生活方式改变似乎是合理和正当的。这些建议应与目前公认的肾结石治疗相结合。
{"title":"Metabolic Syndrome and Nephrolithiasis Risk: Should the Medical Management of Nephrolithiasis Include the Treatment of Metabolic Syndrome?","authors":"J. DiBianco, T. Jarrett, Patrick W. Mufarrij","doi":"10.3909/RIU0650","DOIUrl":"https://doi.org/10.3909/RIU0650","url":null,"abstract":"This article reviews the relationship between metabolic syndrome (MetS) and nephrolithiasis, as well as the clinical implications for patients with this dual diagnosis. MetS, estimated to affect 25% of adults in the United States, is associated with a fivefold increase in the risk of developing diabetes, a doubling of the risk of acquiring cardiovascular disease, and an increase in overall mortality. Defined as a syndrome, MetS is recognized clinically by numerous constitutive traits, including abdominal obesity, hypertension, dyslipidemia (elevated triglycerides, low high-density lipoprotein cholesterol), and hyperglycemia. Urologic complications of MetS include a 30% higher risk of nephrolithiasis, with an increased percentage of uric acid nephrolithiasis in the setting of hyperuricemia, hyperuricosuria, low urine pH, and low urinary volume. Current American Urological Association and European Association of Urology guidelines suggest investigating the etiology of nephrolithiasis in affected individuals; however, there is no specific goal of treating MetS as part of the medical management. Weight loss and exercise, the main lifestyle treatments of MetS, counter abdominal obesity and insulin resistance and reduce the incidence of cardiovascular events and the development of diabetes. These recommendations may offer a beneficial adjunctive treatment option for nephrolithiasis complicated by MetS. Although definitive therapeutic recommendations must await further studies, it seems both reasonable and justifiable for the urologist, as part of a multidisciplinary team, to recommend these important lifestyle changes to patients with both conditions. These recommendations should accompany the currently accepted management of nephrolithiasis.","PeriodicalId":94353,"journal":{"name":"Reviews in urology","volume":"21 1","pages":"117-28"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77761432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 18
Best of the 2015 AUA Annual Meeting: Highlights From the 2015 American Urological Association Annual Meeting, May 15-19, 2015, New Orleans, LA. 2015年美国泌尿协会年会精华:2015年美国泌尿外科协会年会花絮,2015年5月15-19日,洛杉矶新奥尔良。
Pub Date : 2015-01-01
J Curtis Nickel, Michael A Gorin, Alan W Partin, Dean Assimos, Michael Brawer, Heinz Nicolai, Michael B Chancellor, Áine Goggins, Stacy Loeb, Ellen Shapiro
{"title":"Best of the 2015 AUA Annual Meeting: Highlights From the 2015 American Urological Association Annual Meeting, May 15-19, 2015, New Orleans, LA.","authors":"J Curtis Nickel, Michael A Gorin, Alan W Partin, Dean Assimos, Michael Brawer, Heinz Nicolai, Michael B Chancellor, Áine Goggins, Stacy Loeb, Ellen Shapiro","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":94353,"journal":{"name":"Reviews in urology","volume":"17 3","pages":"179-89"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633663/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140195394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metabolic Syndrome and Nephrolithiasis Risk: Should the Medical Management of Nephrolithiasis Include the Treatment of Metabolic Syndrome? 代谢综合征与肾结石风险:肾结石的医疗管理是否应该包括代谢综合征的治疗?
Pub Date : 2015-01-01
John Michael DiBianco, T W Jarrett, Patrick Mufarrij

This article reviews the relationship between metabolic syndrome (MetS) and nephrolithiasis, as well as the clinical implications for patients with this dual diagnosis. MetS, estimated to affect 25% of adults in the United States, is associated with a fivefold increase in the risk of developing diabetes, a doubling of the risk of acquiring cardiovascular disease, and an increase in overall mortality. Defined as a syndrome, MetS is recognized clinically by numerous constitutive traits, including abdominal obesity, hypertension, dyslipidemia (elevated triglycerides, low high-density lipoprotein cholesterol), and hyperglycemia. Urologic complications of MetS include a 30% higher risk of nephrolithiasis, with an increased percentage of uric acid nephrolithiasis in the setting of hyperuricemia, hyperuricosuria, low urine pH, and low urinary volume. Current American Urological Association and European Association of Urology guidelines suggest investigating the etiology of nephrolithiasis in affected individuals; however, there is no specific goal of treating MetS as part of the medical management. Weight loss and exercise, the main lifestyle treatments of MetS, counter abdominal obesity and insulin resistance and reduce the incidence of cardiovascular events and the development of diabetes. These recommendations may offer a beneficial adjunctive treatment option for nephrolithiasis complicated by MetS. Although definitive therapeutic recommendations must await further studies, it seems both reasonable and justifiable for the urologist, as part of a multidisciplinary team, to recommend these important lifestyle changes to patients with both conditions. These recommendations should accompany the currently accepted management of nephrolithiasis.

本文综述了代谢综合征(MetS)与肾结石的关系,以及这种双重诊断对患者的临床意义。MetS估计影响美国25%的成年人,与患糖尿病的风险增加五倍、患心血管疾病的风险增加一倍以及总体死亡率增加有关。MetS被定义为一种综合征,临床上有许多组成特征,包括腹部肥胖、高血压、血脂异常(甘油三酯升高、低密度脂蛋白胆固醇)和高血糖。MetS的泌尿系统并发症包括肾结石的风险增加30%,在高尿酸血症、高尿酸症、低尿液pH值和低尿量的情况下,尿酸肾结石的百分比增加。目前美国泌尿外科协会和欧洲泌尿外科协会的指南建议调查受影响个体的肾结石病因;然而,并没有将MetS作为医疗管理的一部分来治疗的具体目标。减肥和锻炼是代谢综合征的主要生活方式治疗方法,可以对抗腹部肥胖和胰岛素抵抗,降低心血管事件的发生率和糖尿病的发展。这些建议可能为肾结石合并代谢综合征提供一种有益的辅助治疗选择。尽管明确的治疗建议必须等待进一步的研究,但作为多学科团队的一部分,泌尿科医生向患有这两种疾病的患者推荐这些重要的生活方式改变似乎既合理又合理。这些建议应与目前接受的肾结石治疗相结合。
{"title":"Metabolic Syndrome and Nephrolithiasis Risk: Should the Medical Management of Nephrolithiasis Include the Treatment of Metabolic Syndrome?","authors":"John Michael DiBianco,&nbsp;T W Jarrett,&nbsp;Patrick Mufarrij","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This article reviews the relationship between metabolic syndrome (MetS) and nephrolithiasis, as well as the clinical implications for patients with this dual diagnosis. MetS, estimated to affect 25% of adults in the United States, is associated with a fivefold increase in the risk of developing diabetes, a doubling of the risk of acquiring cardiovascular disease, and an increase in overall mortality. Defined as a syndrome, MetS is recognized clinically by numerous constitutive traits, including abdominal obesity, hypertension, dyslipidemia (elevated triglycerides, low high-density lipoprotein cholesterol), and hyperglycemia. Urologic complications of MetS include a 30% higher risk of nephrolithiasis, with an increased percentage of uric acid nephrolithiasis in the setting of hyperuricemia, hyperuricosuria, low urine pH, and low urinary volume. Current American Urological Association and European Association of Urology guidelines suggest investigating the etiology of nephrolithiasis in affected individuals; however, there is no specific goal of treating MetS as part of the medical management. Weight loss and exercise, the main lifestyle treatments of MetS, counter abdominal obesity and insulin resistance and reduce the incidence of cardiovascular events and the development of diabetes. These recommendations may offer a beneficial adjunctive treatment option for nephrolithiasis complicated by MetS. Although definitive therapeutic recommendations must await further studies, it seems both reasonable and justifiable for the urologist, as part of a multidisciplinary team, to recommend these important lifestyle changes to patients with both conditions. These recommendations should accompany the currently accepted management of nephrolithiasis. </p>","PeriodicalId":94353,"journal":{"name":"Reviews in urology","volume":"17 3","pages":"117-28"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633655/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71435075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of the US Preventive Services Task Force Grade D Recommendation: Assessment of Evaluations for Elevated Prostate-specific Antigen and Prostate Biopsies in a Large Urology Group Practice Following Statement Revision. 美国预防服务工作组 D 级建议的影响:美国预防服务特别工作组 D 级建议的影响:《声明修订后对大型泌尿外科团体前列腺特异性抗原升高和前列腺活检的评估》。
Pub Date : 2015-01-01
Kathleen F McGinley, Gregory C McMahon, Gordon A Brown

On October 7, 2011, the United States Preventive Services Task Force (USPSTF) released their evidence statement and grade D recommendation against prostate-specific antigen (PSA)-based prostate cancer screening. Using a time series design, we assessed the effect of this recommendation upon evaluations for elevated PSA levels and prostate biopsies in our large urology group practice. We found that, despite a 24.1% increase in total visits, the 32 urologists in our practice completed 16.4% fewer evaluations for elevated PSA levels (317 fewer evaluations per month; P = .017) and 21.4% fewer prostate biopsies (42 fewer biopsies per month; P = .001) in the 2 years following the USPSTF grade D recommendation.

2011 年 10 月 7 日,美国预防服务工作组 (USPSTF) 发布了证据声明和 D 级建议,反对基于前列腺特异性抗原 (PSA) 的前列腺癌筛查。我们采用时间序列设计,评估了这一建议对我们大型泌尿科小组中 PSA 水平升高评估和前列腺活检的影响。我们发现,尽管总门诊量增加了 24.1%,但在 USPSTF D 级建议提出后的两年内,我们诊所的 32 位泌尿科医生完成的 PSA 水平升高评估减少了 16.4%(每月评估减少 317 例;P = .017),前列腺活检减少了 21.4%(每月活检减少 42 例;P = .001)。
{"title":"Impact of the US Preventive Services Task Force Grade D Recommendation: Assessment of Evaluations for Elevated Prostate-specific Antigen and Prostate Biopsies in a Large Urology Group Practice Following Statement Revision.","authors":"Kathleen F McGinley, Gregory C McMahon, Gordon A Brown","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>On October 7, 2011, the United States Preventive Services Task Force (USPSTF) released their evidence statement and grade D recommendation against prostate-specific antigen (PSA)-based prostate cancer screening. Using a time series design, we assessed the effect of this recommendation upon evaluations for elevated PSA levels and prostate biopsies in our large urology group practice. We found that, despite a 24.1% increase in total visits, the 32 urologists in our practice completed 16.4% fewer evaluations for elevated PSA levels (317 fewer evaluations per month; P = .017) and 21.4% fewer prostate biopsies (42 fewer biopsies per month; P = .001) in the 2 years following the USPSTF grade D recommendation. </p>","PeriodicalId":94353,"journal":{"name":"Reviews in urology","volume":"17 3","pages":"171-7"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633661/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140195395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Best of the 2013 AUA Annual Meeting: Highlights From the 2013 American Urological Association Meeting, May 4-8, 2013, San Diego, CA. 2013年美国泌尿学会年会最佳报告:2013年5月4-8日,圣地亚哥,加州。
Pub Date : 2013-01-01 DOI: 10.3909/RIU0717
S. Loeb, D. Assimos, M. Chancellor, J. Nickel, M. Brawer, A. Kern, A. Partin
Over 2000 posters, abstracts, and videos were presented at the annual meeting of the American Urological Association (AUA), held this year in San Diego, CA, May 4–8, 2013. The editors of Reviews in Urology have culled an enormous volume of information from this premier source and present those findings that are the most relevant to the practicing urologist.
2013年5月4日至8日,在加州圣地亚哥举行的美国泌尿学会(AUA)年会上,超过2000张海报、摘要和视频被展示。《泌尿外科评论》的编辑们从这一主要来源中收集了大量的信息,并提出了那些与泌尿科医生实践最相关的发现。
{"title":"Best of the 2013 AUA Annual Meeting: Highlights From the 2013 American Urological Association Meeting, May 4-8, 2013, San Diego, CA.","authors":"S. Loeb, D. Assimos, M. Chancellor, J. Nickel, M. Brawer, A. Kern, A. Partin","doi":"10.3909/RIU0717","DOIUrl":"https://doi.org/10.3909/RIU0717","url":null,"abstract":"Over 2000 posters, abstracts, and videos were presented at the annual meeting of the American Urological Association (AUA), held this year in San Diego, CA, May 4–8, 2013. The editors of Reviews in Urology have culled an enormous volume of information from this premier source and present those findings that are the most relevant to the practicing urologist.","PeriodicalId":94353,"journal":{"name":"Reviews in urology","volume":"37 1","pages":"72-81"},"PeriodicalIF":0.0,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85198578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A review of current hemostatic agents and tissue sealants used in laparoscopic partial nephrectomy. 目前腹腔镜肾部分切除术中使用的止血剂和组织密封剂的综述。
Pub Date : 2011-01-01 DOI: 10.3909/RIU0524
I. Galanakis, N. Vasdev, N. Soomro
Laparoscopic partial nephrectomy (LPN) is currently considered to be one of the most challenging procedures in minimally invasive urological surgery. With an increasing number of renal tumors being managed using LPN, there is now a further interest in the development of techniques and agents to reduce complications associated with the procedure. Hemostasis is of paramount importance during LPN, and hemostatic agents and tissue sealants are now being used commonly during LPN. Despite this, there is a dearth of prospective, randomized, human trials in current literature that compare the various agents. This review evaluates hemostatic agents and tissue sealants being used during LPN as an adjuvant to suturing in human studies.
腹腔镜部分肾切除术(LPN)目前被认为是微创泌尿外科中最具挑战性的手术之一。随着越来越多的肾脏肿瘤使用LPN进行治疗,现在人们对开发技术和药物来减少与手术相关的并发症有了进一步的兴趣。在LPN中,止血是最重要的,止血剂和组织密封剂现在在LPN中被普遍使用。尽管如此,目前文献中缺乏前瞻性、随机、人体试验来比较各种药物。这篇综述评估了在LPN中使用的止血剂和组织密封剂作为人体研究中缝合的辅助剂。
{"title":"A review of current hemostatic agents and tissue sealants used in laparoscopic partial nephrectomy.","authors":"I. Galanakis, N. Vasdev, N. Soomro","doi":"10.3909/RIU0524","DOIUrl":"https://doi.org/10.3909/RIU0524","url":null,"abstract":"Laparoscopic partial nephrectomy (LPN) is currently considered to be one of the most challenging procedures in minimally invasive urological surgery. With an increasing number of renal tumors being managed using LPN, there is now a further interest in the development of techniques and agents to reduce complications associated with the procedure. Hemostasis is of paramount importance during LPN, and hemostatic agents and tissue sealants are now being used commonly during LPN. Despite this, there is a dearth of prospective, randomized, human trials in current literature that compare the various agents. This review evaluates hemostatic agents and tissue sealants being used during LPN as an adjuvant to suturing in human studies.","PeriodicalId":94353,"journal":{"name":"Reviews in urology","volume":"23 1","pages":"131-8"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82129556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 42
期刊
Reviews in urology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1